Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVersarien Regulatory News (VRS)

Share Price Information for Versarien (VRS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.1005
Bid: 0.10
Ask: 0.1045
Change: 0.00 (0.00%)
Spread: 0.0045 (4.50%)
Open: 0.1005
High: 0.00
Low: 0.00
Prev. Close: 0.1005
VRS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of General Meeting

30 Oct 2023 11:52

RNS Number : 7331R
Versarien PLC
30 October 2023
 

30 October 2023

Versarien Plc

("Versarien" or the "Company")

Result of General Meeting

Versarien Plc (AIM: VRS), the advanced materials engineering group, is pleased to confirm that at the Company's General Meeting held earlier today, all resolutions were duly passed. Full details of the resolutions are set out in the Notice of General Meeting dated 12 October 2023 and available on the Company's website at: https://www.versarien.com/investors/reports-and-presentations/

The proxy votes cast were as follows:

Resolution

For

 

Against

 

Abstain

1 - to sub-divide the Existing Ordinary Shares into New Ordinary Shares and Deferred Shares

 

23,267,848

96.07%

951,505

3.93%

645,931

2 - to alter the Articles to allow for the issue of New Deferred Shares

 

23,260,834

95.77%

1,027,547

4.23%

576,903

3 - to authorise the Directors to allot shares in the Company

 

22,845,045

95.73%

1,019,150

4.27%

1,001,089

4 - to disapply statutory pre-emption rights

 

22,609,443

94.75%

1,253,097

5.25%

1,002,744

 

Share Capital Reorganisation

Following the passing of the resolutions at the General Meeting, each of the Company's 330,779,690 Existing Ordinary Shares will be sub-divided into one New Ordinary Share of 0.1p (the "New Ordinary Shares") and one deferred share of 0.9p ("New Deferred Shares"). The New Deferred Shares will have little economic value as they will not carry any rights to vote or dividend rights, although the New Deferred Shares will rank pari passu with the New Ordinary Shares on a return of capital or on a winding up of the Company.

 

Admission to AIM and Total Voting Rights

Dealings on AIM in the Existing Ordinary Shares is expected to cease at the close of business on 30 October 2023. Application has been made for the admission of 330,779,690 New Ordinary Shares to trading on AIM ("Admission") and it is expected that Admission will take place and that trading in the New Ordinary Shares will commence at 8.00 a.m. on or around 31 October 2023. No application will be made for admission of the New Deferred Shares to trading on AIM nor will any such application be made to any other exchange.

Following Admission, there will be a total of 330,779,690 New Ordinary Shares, with voting rights, in issue. The Company does not hold any shares in treasury. Consequently, 330,779,690 is the figure which may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

Unless otherwise indicated, all defined terms in this announcement shall have the same meaning as described in the Company's announcement dated 12 October 2023 and the Circular which was posted to shareholders on the same day.

 

 

For further information please contact:

 

Versarien

Stephen Hodge, Chief Executive Officer

Chris Leigh, Chief Financial Officer

c/o IFC

SP Angel Corporate Finance (Nominated Adviser and Broker)

Matthew Johnson, Adam Cowl

+44 (0)20 3470 0470

 

 

IFC Advisory Limited (Financial PR and Investor Relations)

Tim Metcalfe, Zach Cohen

+44 (0) 20 3934 6630

 

For further information please see: http://www.versarien.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ROMWPGGAUUPWGGU
Date   Source Headline
22nd Jul 20147:00 amRNSFinal Results
8th Jul 20147:00 amRNSNotice of Preliminary Results
30th Jun 20143:08 pmRNSTotal Voting Rights
17th Jun 20143:05 pmRNSIssue of Equity
6th May 201410:35 amRNSHolding(s) in Company
2nd May 20144:43 pmRNSHolding(s) in Company
2nd May 20143:22 pmRNSHolding(s) in Company
30th Apr 20144:33 pmRNSHolding(s) in Company
30th Apr 201412:07 pmRNSResult of General Meeting
28th Apr 201411:17 amRNSHolding(s) in Company
16th Apr 20144:52 pmRNSHolding(s) in Company
14th Apr 20147:00 amRNSAcquisition of 2-DTech Limited & £5.5m Placing
10th Apr 20147:00 amRNSChange of Adviser
19th Mar 20147:00 amRNSTrading Update
19th Feb 20147:00 amRNSHolding(s) in Company
19th Feb 20147:00 amRNSHolding(s) in Company
3rd Feb 20147:00 amRNSHolding(s) in Company
27th Jan 20148:30 amRNSHolding(s) in Company
16th Jan 20147:00 amRNSInvestor Site Visit
11th Dec 20138:46 amRNSHolding(s) in Company
3rd Dec 20137:00 amRNSInterim Results
3rd Oct 20137:00 amRNSDistribution Agreement
1st Oct 20134:24 pmRNSDirector/PDMR Shareholding
30th Sep 201310:30 amRNSVersarien Launches its First Ever Water-Cooled PC
27th Sep 20137:00 amRNSFinal Results
21st Aug 20139:00 amRNSNotification of Shareholding
16th Aug 20137:00 amRNSHolding(s) in Company
5th Aug 20137:00 amRNSCEO to join GFirst board
16th Jul 20137:00 amRNSGrant awarded from Technology Strategy Board
3rd Jul 20139:00 amRNSAppointment of Finance Director
12th Jun 20137:00 amRNSAIM Admission

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.